Diabetes tipo 2: a cuidar el corazón

Tema: Diabetes tipo 2 y riesgo cardiovascular
Fuente: Dra. Carmen Gloria Aylwin
Fecha: 19/08/2018
Link: http://www.carlosjorquera.com/dra-aylwin-lacuarta.jpg
Multicentre study of maternal and neonatal outcomes in individuals with Prader-Willi syndrome.
Singh P, Mahmoud R, Gold JA, Miller JL, Roof E, Tamura R, et al.
J Med Genet. 2018 May 18. pii: jmedgenet-2017-105118.
http://doi.org/10.1136/jmedgenet-2017-105118
Neonatal Features of the Prader-Willi Syndrome; The Case for Making the Diagnosis During the First Week of Life.
Çizmecioğlu FM, Jones JH, Paterson WF, Kherra S, Kourime M, McGowan R, et al.
J Clin Res Pediatr Endocrinol. 2018 Jul 31;10(3):264-273.
http://doi.org/10.4274/jcrpe.0029
Growth hormone – past, present and future.
Ranke MB, Wit JM.
Nat Rev Endocrinol. 2018 May;14(5):285-300
http://doi.org/10.1038/nrendo.2018.22
The current state of long-acting growth hormone preparations for growth hormone therapy.
Yuen KCJ, Miller BS, Biller BMK.
Curr Opin Endocrinol Diabetes Obes. 2018 Aug;25(4):267-273.
http://doi.org/10.1097/MED.0000000000000416
Comentarios recientes